Neimeth International Pharmaceuticals Plc has notified the market that Clinoscope Services Limited, one of its substantial shareholders, disposed of company shares worth N3.117 billion.
A notification on the Nigerian Exchange showed that the shareholder sold 515,300,515 NEIMETH shares at an average price of N6.05 per unit.
The sale comes after a strong year-to-date performance by the pharmaceutical company on the NGX, where the stock has returned about 162% to investors in 2025.